Myopia Control
in Blue Bell, PA
Myopia (nearsightedness) in children doesn't have to keep getting worse. We offer four proven treatments — MiSight, Ortho-K, Stellest, and atropine — to slow progression and protect your child's long-term vision health.
Why Myopia Control Matters
Myopia is more than blurry distance vision — it's a structural change in the eye. As the eye grows too long, the retina stretches and thins, dramatically increasing the lifetime risk of serious complications.
Every diopter of myopia matters. A child who reaches -6.00 by adulthood has a 40× higher risk of retinal detachment than someone with no myopia. Myopia control treatments don't eliminate progression, but they meaningfully reduce the final prescription — and with it, the associated risks.
Our Myopia Control Treatments
We offer every major evidence-based option so we can match the right treatment to each child's lifestyle, age, and prescription.
MiSight® 1 Day
The Only FDA-Approved Daily Contact Lens for Myopia Control
MiSight® 1 day by CooperVision is the first and only FDA-approved soft contact lens specifically designed to slow the progression of myopia in children aged 8–12 at the initiation of treatment. Unlike standard contact lenses that simply correct blurry vision, MiSight uses ActivControl® Technology — a dual-focus optical design that simultaneously corrects distance vision while creating a myopic defocus signal that tells the eye to stop growing.
Clinical trials spanning 6 years demonstrated that MiSight slows myopia progression by an average of 59% compared to single-vision lenses, and reduces axial elongation (eye growth) by 52%. Children who started treatment younger and continued consistently showed the greatest benefit.
Key Benefits
- FDA-approved — the only soft lens with this designation for myopia control
- Daily disposable — no cleaning, no cases, maximum hygiene
- 59% average reduction in prescription progression over 6 years
- Comfortable for full-day wear, including sports and outdoor activities
- Builds independence and confidence in children
- Suitable for ages 8 and up
Children aged 8–15 with progressing myopia who are ready for contact lenses.
Orthokeratology (Ortho-K / CRT)
See Clearly All Day — No Glasses or Contacts Required
Orthokeratology — also called Ortho-K or Corneal Refractive Therapy (CRT) — uses specially designed rigid gas-permeable lenses worn only during sleep. While the child sleeps, the lenses gently reshape the front surface of the cornea. When they wake up and remove the lenses, they can see clearly throughout the entire day without any glasses or contact lenses.
At ProVision, we fit both the Abiliti CRT™ lens and standard Ortho-K designs. Beyond the lifestyle benefit, Ortho-K is one of the most effective myopia control strategies available — studies show it reduces axial elongation by 40–60% compared to standard glasses. It is particularly effective for children who are active in sports, swimming, or other activities where glasses are inconvenient.
Key Benefits
- Completely glasses-free and contact-free during waking hours
- 40–60% reduction in eye growth compared to standard glasses
- Reversible — cornea returns to its original shape if lenses are discontinued
- Ideal for sports, swimming, and active lifestyles
- No daytime lens handling — lenses are only worn at night
- Abiliti CRT™ and standard Ortho-K designs available
Children and teens who want freedom from daytime eyewear, especially those active in sports or swimming.
Stellest® HALT Lenses
Advanced Myopia Control in an Everyday Eyeglass Lens
Stellest® lenses by Essilor use H.A.L.T. (Highly Aspherical Lenslet Target) technology — a constellation of 1,021 lenslets arranged across the lens surface that create a volume of signal in front of the retina, signaling the eye to slow its growth. Unlike traditional progressive or bifocal lenses, Stellest lenses work in every direction of gaze.
In a 3-year clinical study, children wearing Stellest lenses full-time showed 67% slower myopia progression compared to those wearing standard single-vision lenses. Stellest is an excellent option for children who are not yet ready for contact lenses, or as a complement to other myopia control strategies.
Key Benefits
- 67% slower myopia progression in 3-year clinical trials
- Works in all directions of gaze — no "sweet spot" required
- Looks and feels like a regular pair of glasses
- No adaptation period — children adjust immediately
- Compatible with most frame styles
- Ideal for children not ready for contact lenses
Children aged 6 and up who wear glasses full-time and are not yet candidates for contact lenses.
Low-Dose Atropine Therapy
A Proven Pharmaceutical Approach to Slowing Myopia
Low-dose atropine eye drops (typically 0.01%–0.05%) have been studied extensively as a myopia control strategy, with the ATOM and LAMP studies demonstrating meaningful reductions in progression. Atropine works by blocking muscarinic receptors in the eye, reducing the stimulus for axial elongation.
At ProVision, we use low-dose atropine as a standalone treatment for children who are not candidates for contact lenses, or in combination with MiSight or Ortho-K for a synergistic effect in rapidly progressing cases. The drops are typically applied once nightly and have minimal side effects at low concentrations.
Key Benefits
- Evidence-based — supported by multiple large-scale clinical trials
- Simple once-nightly drop application
- Minimal side effects at low concentrations (0.01%–0.05%)
- Can be combined with MiSight or Ortho-K for enhanced effect
- Monitored with regular follow-up visits
- Available as a compounded prescription
Children with rapidly progressing myopia, or as an adjunct to contact lens-based myopia control.
Low-Dose Atropine
A simple once-nightly eye drop with decades of clinical evidence behind it.
Which Treatment Is Right for My Child?
A quick comparison to help you start the conversation at your consultation.
| Treatment | Min. Age | Daytime Eyewear | Efficacy | Best For |
|---|---|---|---|---|
| MiSight® 1 Day | 8+ | Contact lenses | ~59% | Active kids ready for contacts |
| Ortho-K / CRT | 6+ | None needed | 40–60% | Sports, swimming, glasses-free lifestyle |
| Stellest® HALT | 6+ | Glasses | ~67% | Children not ready for contacts |
| Low-Dose Atropine | Any | Glasses or contacts | Variable | Adjunct or rapid progressors |
Efficacy figures represent average reduction in myopia progression vs. standard single-vision correction from published clinical trials.
Frequently Asked Questions
Start Protecting Your Child's Vision Today
Schedule a myopia control consultation with Dr. Capel. We'll review your child's prescription history, measure axial length, and recommend the best treatment plan.
Most insurance plans cover the exam. Myopia control treatment costs vary by modality — we'll review options at your consultation.